HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clopidogrel effective for frequent transient monocular blindness caused by vulnerable plaque.

Abstract
Transient monocular blindness (TMB) is a well-known warning symptom of impending cerebral or retinal infarction, which suggests vulnerable ipsilateral carotid disease. Instability of free-floating thrombus may cause recurrent artery-to-artery embolism. A recent study showed that a combination of clopidogrel and aspirin might reduce microthromboembolisms. Here, we report a patient with frequent TMB despite aspirin monotherapy whose symptom disappeared after the addition of clopidogrel. This is the first report of aspirin-resistant frequent TMB caused by thromboembolism from vulnerable plaque that remitted after the addition of clopidogrel. These findings highlight the need for a randomized controlled trial to illustrate the most efficacious treatment strategy in this situation.
AuthorsHong-Kyun Park, Hang Rai Kim, Beom Joon Kim, Jihoon Kang, Cheolkyu Jung, Byung Se Choi, Jae Hyoung Kim, Moon-Ku Han, Seong-Ho Park, Hee-Joon Bae
JournalJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (J Clin Neurosci) Vol. 20 Issue 10 Pg. 1455-7 (Oct 2013) ISSN: 1532-2653 [Electronic] Scotland
PMID23845263 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
Topics
  • Angiography, Digital Subtraction
  • Blindness (drug therapy, etiology)
  • Clopidogrel
  • Humans
  • Magnetic Resonance Angiography
  • Male
  • Middle Aged
  • Plaque, Atherosclerotic (complications)
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Ticlopidine (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: